NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,160 filers reported holding NOVARTIS A G in Q1 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $3,887,000 | +98305.1% | 42,250 | -3.0% | 0.11% | -5.4% |
| Q4 2022 | $3,950 | -99.9% | 43,544 | -5.5% | 0.11% | +2.8% |
| Q3 2022 | $3,504,000 | -13.5% | 46,100 | -3.9% | 0.11% | -4.4% |
| Q2 2022 | $4,053,000 | -7.7% | 47,950 | -4.2% | 0.11% | +7.5% |
| Q1 2022 | $4,392,000 | +33.9% | 50,048 | +33.5% | 0.11% | +30.9% |
| Q4 2021 | $3,280,000 | -30.1% | 37,500 | -34.6% | 0.08% | -25.7% |
| Q3 2021 | $4,691,000 | -30.2% | 57,364 | -22.2% | 0.11% | -26.8% |
| Q2 2021 | $6,725,000 | +18.3% | 73,709 | +10.8% | 0.15% | +14.6% |
| Q1 2021 | $5,684,000 | -17.8% | 66,500 | -9.2% | 0.13% | -7.8% |
| Q4 2020 | $6,913,000 | +7.3% | 73,211 | -1.1% | 0.14% | -1.4% |
| Q3 2020 | $6,440,000 | -12.9% | 74,056 | -12.6% | 0.14% | -16.4% |
| Q2 2020 | $7,397,000 | -13.6% | 84,688 | -18.4% | 0.17% | -21.9% |
| Q1 2020 | $8,557,000 | -15.1% | 103,781 | -2.5% | 0.22% | +6.3% |
| Q4 2019 | $10,082,000 | +18.5% | 106,475 | +8.7% | 0.21% | +9.6% |
| Q3 2019 | $8,511,000 | -0.9% | 97,945 | +4.2% | 0.19% | -1.1% |
| Q2 2019 | $8,586,000 | +37.7% | 94,036 | +45.0% | 0.19% | +33.8% |
| Q1 2019 | $6,236,000 | +62.5% | 64,863 | +45.0% | 0.14% | +43.4% |
| Q4 2018 | $3,838,000 | +6.3% | 44,726 | +6.7% | 0.10% | -2.0% |
| Q3 2018 | $3,612,000 | +36.3% | 41,917 | +19.5% | 0.10% | +27.8% |
| Q2 2018 | $2,650,000 | -9.0% | 35,082 | -2.6% | 0.08% | -12.2% |
| Q1 2018 | $2,912,000 | -10.1% | 36,020 | -6.6% | 0.09% | -10.9% |
| Q4 2017 | $3,238,000 | +6.8% | 38,569 | +9.2% | 0.10% | +5.2% |
| Q3 2017 | $3,031,000 | +35.2% | 35,306 | +31.5% | 0.10% | +29.7% |
| Q2 2017 | $2,242,000 | +17.4% | 26,857 | +4.5% | 0.07% | +13.8% |
| Q1 2017 | $1,909,000 | -1.8% | 25,701 | -3.7% | 0.06% | -7.1% |
| Q4 2016 | $1,944,000 | -37.3% | 26,691 | -32.1% | 0.07% | -40.2% |
| Q3 2016 | $3,102,000 | -3.5% | 39,292 | +0.8% | 0.12% | -5.6% |
| Q2 2016 | $3,215,000 | +38.2% | 38,969 | +21.4% | 0.12% | +22.8% |
| Q1 2016 | $2,326,000 | +11.5% | 32,109 | +32.4% | 0.10% | +12.2% |
| Q4 2015 | $2,087,000 | -9.2% | 24,259 | -3.0% | 0.09% | -10.9% |
| Q3 2015 | $2,298,000 | +16.1% | 24,998 | +24.2% | 0.10% | +18.8% |
| Q2 2015 | $1,980,000 | +28.6% | 20,133 | +28.9% | 0.08% | +26.9% |
| Q1 2015 | $1,540,000 | +14.7% | 15,617 | +7.7% | 0.07% | +9.8% |
| Q4 2014 | $1,343,000 | -4.1% | 14,498 | -2.6% | 0.06% | -14.1% |
| Q3 2014 | $1,401,000 | +25.8% | 14,884 | +21.0% | 0.07% | +26.8% |
| Q2 2014 | $1,114,000 | +11.8% | 12,305 | +5.1% | 0.06% | +1.8% |
| Q1 2014 | $996,000 | +4.7% | 11,710 | -1.1% | 0.06% | +3.8% |
| Q4 2013 | $951,000 | +1.2% | 11,835 | -3.4% | 0.05% | -13.1% |
| Q3 2013 | $940,000 | +3.2% | 12,253 | -4.9% | 0.06% | +13.0% |
| Q2 2013 | $911,000 | – | 12,883 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEXTHERA CAPITAL LP | 198,000 | $14,422,000 | 8.45% |
| PRENTISS SMITH & CO INC | 133,202 | $9,702,000 | 5.92% |
| EXENCIAL WEALTH ADVISORS, LLC | 178,313 | $12,988,000 | 5.50% |
| MANAGED ASSET PORTFOLIOS, LLC | 185,868 | $13,538,000 | 5.33% |
| Osher Van de Voorde Investment Management | 114,735 | $8,357,000 | 4.59% |
| BROWN BROTHERS HARRIMAN & CO | 10,971,272 | $799,147,000 | 4.37% |
| PROFESSIONAL ADVISORY SERVICES INC | 238,542 | $17,375,000 | 4.04% |
| Elefante Mark B | 4,579 | $333,000 | 4.02% |
| COMPASS CAPITAL MANAGEMENT, INC | 271,536 | $19,779,000 | 3.69% |
| CGOV Asset Management | 972,731 | $95,135,000 | 3.51% |